Ann: Proposed Equity Raising, page-23

First 23 Last

Share
Profile

Follow
schmoove

1,687 Posts.

252

05/12/17

00:09

Post #: 29366636
Share

Originally posted by nytryda ↑

I tipped this on the STT thread based on a CR pump and also this....

"Earlier this year, they turned to PAC partners to provide research and help build investor awareness. In the quarterly report ending 30/6/17, TMT have stated that PAC Partners will be issued 1.0 million options exercisable at $0.35 expiring on 31 July 2020 for achieving a 30 day VWAP above $0.40 on or prior to December 31 2017.
Source: https://hotcopper.com.au/threads/an...d-appendix-5b-june-2017.3577950/#.WiKiGTcRXb0 Page 8

TMT's tenements are contiguous to that of AVL's, being to north and south. AVL announced recently that they have appointed a specialist commodity marketing and strategic advisor group, Mastermines (David Gillam aka sinkorswim). Yesterday, AVL announced that Mastermines' promotional trip to China is underway to meet with existing and new contacts in the vanadium sector. One would think that any exposure AVL get would translate very nicely for TMT. This is basically a free kick for TMT.

With the bonus options to achieve a 30-day VWAP above $0.40 by the end of this year in mind, and only 18 trading days left, it's possible that TMT could trade as high as $0.50 or $0.60."

Please DYOR as this is not a buy recommendation.

https://hotcopper.com.au/threads/sh...3882602/page-92?post_id=29322410#.WiVEqTcRXb0

Expand

If this hits a VWAP above 40c for those bonus options all you lot on the board can come around my house for an unlimited chicken and beer party for an entire month

TMT Price at posting: 21.0¢ Sentiment: Hold Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

3 stocks with antimony news on Thursday

CU6

Clarity progresses SECuRE trial with positive safety results

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3